Scientists seek clues in blood to unlock mystery of Ultra-Rare cancer
NCT ID NCT06680401
Summary
This study aims to better understand a very rare cancer called epithelioid haemangioendothelioma (EHE). Researchers will observe 50 patients to collect detailed information on how the disease presents, its natural course, and how patients respond to treatments. The main goal is to identify substances in the blood that could serve as future markers for the disease and to create lab models from patient samples to test new drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NATURAL HISTORY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fondazione IRCCS IstitutoNazionale dei Tumori
RECRUITINGMilan, 20133, Italy
Contact Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.